PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for CMPS (Compass Pathways PLC) from 2020 to May 09 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Compass Pathways PLC stock (CMPS) PE ratio as of May 09 2021 is 0. More Details

Compass Pathways PLC PE Ratio (TTM) Chart

EMBED

Compass Pathways PLC PE Ratio (TTM) Historical Data

Total 163
  • 1
  • 2
Compass Pathways PLC PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2021-05-090.0 2021-03-080.0
2021-05-070.0 2021-03-050.0
2021-05-060.0 2021-03-040.0
2021-05-050.0 2021-03-030.0
2021-05-040.0 2021-03-020.0
2021-05-030.0 2021-03-010.0
2021-04-300.0 2021-02-260.0
2021-04-290.0 2021-02-250.0
2021-04-280.0 2021-02-240.0
2021-04-270.0 2021-02-230.0
2021-04-260.0 2021-02-220.0
2021-04-230.0 2021-02-190.0
2021-04-220.0 2021-02-180.0
2021-04-210.0 2021-02-170.0
2021-04-200.0 2021-02-160.0
2021-04-190.0 2021-02-150.0
2021-04-160.0 2021-02-120.0
2021-04-150.0 2021-02-110.0
2021-04-140.0 2021-02-100.0
2021-04-130.0 2021-02-090.0
2021-04-120.0 2021-02-080.0
2021-04-090.0 2021-02-050.0
2021-04-080.0 2021-02-040.0
2021-04-070.0 2021-02-030.0
2021-04-060.0 2021-02-020.0
2021-04-050.0 2021-02-010.0
2021-04-020.0 2021-01-290.0
2021-04-010.0 2021-01-280.0
2021-03-310.0 2021-01-270.0
2021-03-300.0 2021-01-260.0
2021-03-290.0 2021-01-250.0
2021-03-260.0 2021-01-220.0
2021-03-250.0 2021-01-210.0
2021-03-240.0 2021-01-200.0
2021-03-230.0 2021-01-190.0
2021-03-220.0 2021-01-150.0
2021-03-190.0 2021-01-140.0
2021-03-180.0 2021-01-130.0
2021-03-170.0 2021-01-120.0
2021-03-160.0 2021-01-110.0
2021-03-150.0 2021-01-080.0
2021-03-120.0 2021-01-070.0
2021-03-110.0 2021-01-060.0
2021-03-100.0 2021-01-050.0
2021-03-090.0 2021-01-040.0

Compass Pathways PLC PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Compass Pathways PLC logo

Business Description

Compare
Traded in other countries
Address
1 Ashley Road, 3rd Floor, Altrincham, Cheshire, GBR, WA14 2DT
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.